FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042792012> ?p ?o ?g. }

• W2042792012 abstract "ABSTRACT ABSTRACT Hepatitis B and hepatitis C are two common pathogens causing chronic hepatitis in patients with end‐stage renal disease (ESRD). With the acceptance of hepatitis B s antigen (HBsAg) screening, infected patients have been identified and isolated over the past 20 years. Consequently, hepatitis B is now being seen less frequently in dialysis units. Even though hepatitis B has become less of a problem, non‐A, non‐B hepatitis has been recognized as a sigmlicant problem since 1979. With the availability of serological testing for hepatitis C virus (HCV), more specific information is now available in regard to HCV infection in dialysis patients. The prevalence of anti‐HCV in haemodialysis (HD) patients is quite variable, ranging from 5 to over 50%. Anti‐HCV positivity is associated with previous blood transfusions, mode of therapy and duration of haemodialysis. In Spain and Italy, the annual seroconversion rates of HCV antibodies in dialysis patients are 2–9%; this rate was much higher in Taiwan (15%). Whether patients with HCV infection should be identified and isolated during HD treatment is an issue of controversy. Transplantation is associated with increases in hepatitis B virus (HBV) replicative markers. The survival disadvantage in HBsAg‐positive recipients usually did not become apparent until 8 years after transplantation. Hepatitis C virus‐infected renal transplant recipients are presumably in a similar situation to patients with hepatitis B, although confirmatory data are currently lacking. Coinfection of HBV and HCV may lead to aggressive liver disease and cirrhosis. A hepatitis B vaccine is recommended for all susceptible dialysis patients. Dialysis patients have lower response rates to hepatius B vaccines than do other people. Currently, no vaccine is available for hepatitis C. To date, there are no effective treatments available for hepatitis B and hepatitis C. Combination therapy with interferodlamivudine for hepatitis B and interferodribavirin for hepatitis C may offer a promise of effective control of viral replication in the future." @default.
• W2042792012 created "2016-06-24" @default.
• W2042792012 creator A5065157240 @default.
• W2042792012 date "1997-10-01" @default.
• W2042792012 modified "2023-10-10" @default.
• W2042792012 title "Hepatitis in patients with end‐stage renal disease" @default.
• W2042792012 cites W1620465551 @default.
• W2042792012 cites W1964120253 @default.
• W2042792012 cites W1977473337 @default.
• W2042792012 cites W1977972110 @default.
• W2042792012 cites W1978106852 @default.
• W2042792012 cites W1992027097 @default.
• W2042792012 cites W2001140939 @default.
• W2042792012 cites W2002316292 @default.
• W2042792012 cites W2010038708 @default.
• W2042792012 cites W2023361327 @default.
• W2042792012 cites W2024866756 @default.
• W2042792012 cites W2042086569 @default.
• W2042792012 cites W2044294753 @default.
• W2042792012 cites W2044445290 @default.
• W2042792012 cites W2056524016 @default.
• W2042792012 cites W2060985365 @default.
• W2042792012 cites W2063454558 @default.
• W2042792012 cites W2063838325 @default.
• W2042792012 cites W2066945643 @default.
• W2042792012 cites W2068574509 @default.
• W2042792012 cites W2077439054 @default.
• W2042792012 cites W2079002457 @default.
• W2042792012 cites W2086109795 @default.
• W2042792012 cites W2090766473 @default.
• W2042792012 cites W2106742665 @default.
• W2042792012 cites W2113260294 @default.
• W2042792012 cites W2124567096 @default.
• W2042792012 cites W2126744806 @default.
• W2042792012 cites W2153148376 @default.
• W2042792012 cites W2157942522 @default.
• W2042792012 cites W2163441014 @default.
• W2042792012 cites W2165151962 @default.
• W2042792012 cites W2335969006 @default.
• W2042792012 cites W2336905550 @default.
• W2042792012 cites W2916593413 @default.
• W2042792012 cites W4242803079 @default.
• W2042792012 doi "https://doi.org/10.1111/j.1440-1746.1997.tb00506.x" @default.
• W2042792012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9407343" @default.
• W2042792012 hasPublicationYear "1997" @default.
• W2042792012 type Work @default.
• W2042792012 sameAs 2042792012 @default.
• W2042792012 citedByCount "59" @default.
• W2042792012 countsByYear W20427920122012 @default.
• W2042792012 countsByYear W20427920122014 @default.
• W2042792012 countsByYear W20427920122016 @default.
• W2042792012 countsByYear W20427920122017 @default.
• W2042792012 countsByYear W20427920122019 @default.
• W2042792012 countsByYear W20427920122022 @default.
• W2042792012 crossrefType "journal-article" @default.
• W2042792012 hasAuthorship W2042792012A5065157240 @default.
• W2042792012 hasConcept C126322002 @default.
• W2042792012 hasConcept C203014093 @default.
• W2042792012 hasConcept C2522874641 @default.
• W2042792012 hasConcept C2776029263 @default.
• W2042792012 hasConcept C2776408679 @default.
• W2042792012 hasConcept C2776455275 @default.
• W2042792012 hasConcept C2777075537 @default.
• W2042792012 hasConcept C2777214474 @default.
• W2042792012 hasConcept C2777382497 @default.
• W2042792012 hasConcept C2777410769 @default.
• W2042792012 hasConcept C2777451964 @default.
• W2042792012 hasConcept C2777813720 @default.
• W2042792012 hasConcept C2778063415 @default.
• W2042792012 hasConcept C2779978075 @default.
• W2042792012 hasConcept C2780593183 @default.
• W2042792012 hasConcept C2911091166 @default.
• W2042792012 hasConcept C3019040382 @default.
• W2042792012 hasConcept C71924100 @default.
• W2042792012 hasConceptScore W2042792012C126322002 @default.
• W2042792012 hasConceptScore W2042792012C203014093 @default.
• W2042792012 hasConceptScore W2042792012C2522874641 @default.
• W2042792012 hasConceptScore W2042792012C2776029263 @default.
• W2042792012 hasConceptScore W2042792012C2776408679 @default.
• W2042792012 hasConceptScore W2042792012C2776455275 @default.
• W2042792012 hasConceptScore W2042792012C2777075537 @default.
• W2042792012 hasConceptScore W2042792012C2777214474 @default.
• W2042792012 hasConceptScore W2042792012C2777382497 @default.
• W2042792012 hasConceptScore W2042792012C2777410769 @default.
• W2042792012 hasConceptScore W2042792012C2777451964 @default.
• W2042792012 hasConceptScore W2042792012C2777813720 @default.
• W2042792012 hasConceptScore W2042792012C2778063415 @default.
• W2042792012 hasConceptScore W2042792012C2779978075 @default.
• W2042792012 hasConceptScore W2042792012C2780593183 @default.
• W2042792012 hasConceptScore W2042792012C2911091166 @default.
• W2042792012 hasConceptScore W2042792012C3019040382 @default.
• W2042792012 hasConceptScore W2042792012C71924100 @default.
• W2042792012 hasIssue "9-10" @default.
• W2042792012 hasLocation W20427920121 @default.
• W2042792012 hasLocation W20427920122 @default.
• W2042792012 hasOpenAccess W2042792012 @default.
• W2042792012 hasPrimaryLocation W20427920121 @default.
• W2042792012 hasRelatedWork W1951531280 @default.
• W2042792012 hasRelatedWork W1998109795 @default.
• W2042792012 hasRelatedWork W2002550617 @default.

• next